Benge Jared F, Balsis Steve, Madeka Taronish, Uhlman Claire, Lantrip Crystal, Soileau Michael J
Division of Neuropsychology, Department of Neurology, Scott & White Medical Center, 2401 S. 31st Street, Temple, TX 76508, USA; Plummer Movement Disorders Center, Scott & White Medical Center, 2401 S. 31st Street, Temple, TX 76508, USA; Department of Internal Medicine, Texas A&M Health Sciences Center, 2401 S. 31st Street, Temple, TX 76508, USA.
Department of Psychology, Texas A&M University, 4235 TAMU, College Station, TX 77840, USA.
Parkinsonism Relat Disord. 2017 Aug;41:104-108. doi: 10.1016/j.parkreldis.2017.05.023. Epub 2017 May 25.
The Montreal Cognitive Assessment (MoCA) is a frequently utilized cognitive screening tool that has attractive clinical attributes when utilized in individuals with Parkinson's disease. However, the construct validity of this instrument has not been well-characterized in Parkinson's samples. The purpose of this study is to explore the underlying factor structure of the MoCA in individuals with early stage Parkinson's disease.
Item responses from the MoCA in 357 individuals with Parkinson's disease from the Parkinson's Progression Markers Initiative were analyzed first for frequency of errors and polychoric inter item correlations. This correlation matrix was then analyzed with exploratory factor analysis.
Omitting items with ceiling effects, three factors emerged which explained the majority of the variance. These factors were reflective of executive dysfunction, memory, and verbal attention. Scores on the MoCA and all of its subscales were significantly different between individuals with Parkinson's disease-no cognitive impairment and those who met criteria for mild cognitive impairment.
In keeping with prior studies in Parkinson's disease, executive dysfunction seems to underpin performance of many items of the MoCA. Implications of this finding both in terms of optimizing the MoCA for use in this population and further steps to validate the constructs behind the MoCA are discussed.
蒙特利尔认知评估量表(MoCA)是一种常用的认知筛查工具,在帕金森病患者中使用时具有吸引人的临床特性。然而,该工具在帕金森病样本中的结构效度尚未得到充分表征。本研究的目的是探讨早期帕金森病患者中MoCA的潜在因素结构。
首先分析了帕金森病进展标志物倡议中357例帕金森病患者的MoCA项目反应,以确定错误频率和多项目相关。然后用探索性因素分析对该相关矩阵进行分析。
剔除具有天花板效应的项目后,出现了三个因素,它们解释了大部分方差。这些因素反映了执行功能障碍、记忆和言语注意力。帕金森病无认知障碍患者与符合轻度认知障碍标准的患者在MoCA及其所有子量表上的得分存在显著差异。
与先前关于帕金森病的研究一致,执行功能障碍似乎是MoCA许多项目表现的基础。讨论了这一发现对于优化MoCA在该人群中的使用以及进一步验证MoCA背后结构的意义。